{"symbol":"PFE","fiscalQuarter":"Q4-2025","reportDate":"2026-02-03","reportTime":"BMO","status":"reported","company":{"name":"Pfizer Inc.","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/PFE/earnings/Q4-2025","postBrief":{"headline":"Pfizer Beats on EPS, Stock Down 3.34%","keyNumbers":[{"metric":"EPS","actual":"$0.66","expected":"N/A","surprise":"+16.81%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted ongoing efforts to enhance product pipeline.","They acknowledged challenges in the current market environment.","Focus remains on long-term growth despite short-term pressures."],"summary":"Management expressed a cautious optimism about future prospects. They emphasized the importance of innovation and adapting to market changes."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Pfizer's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 3.34% likely due to the lack of revenue details and guidance, which left investors uncertain about future performance. The cautious tone from management may also have contributed to the stock's decline.","metaDescription":"Pfizer Inc (PFE) Q4 2025 earnings: EPS beat by 16.81%. Stock down 3.34%. Full breakdown."}}